Telomeres are the protective caps on the ends of your chromosomes. They shorten each time a cell divides, and when they get short enough the cell stops dividing. That is about as close to a mechanism of ageing as biology gets, and it won a Nobel Prize.
So a serum that protects the telomeres of skin cells sounds like it is aimed at the root rather than the symptoms. That is the story sold around teprenone, marketed as Renovage, and the usual way to check it would be to ask how strong the evidence is.
That framing concedes too much. There is one study. It did not measure a telomere. Not weakly, not indirectly, not with an imperfect proxy. The word carrying the entire premium appears nowhere in the measurements, and the gap is not between strong and weak evidence but between what was tested and what is printed on the box.
Before it was anywhere near a face, teprenone was a drug.
Under the name geranylgeranylacetone, sold as Selbex, it has been prescribed in Japan since 1984 for gastritis and stomach ulcers. Its mechanism there is documented and unglamorous: it prompts cells to produce heat-shock proteins, the cellular first-responders that help protect the stomach lining under stress.
That is real medicine with a real mechanism, and it is worth holding onto, because it is the source of the ingredient's scientific credibility. The heat-shock biology is genuine. It was established in gastric tissue, by a prescription drug, taken internally.
Around 2007 the French ingredient house Sederma dissolved the same molecule in a light carrier oil, trademarked it Renovage, and built the marketing not around heat-shock proteins but around telomeres.
The evidence base for Renovage is essentially one clinical study, produced by the company selling the ingredient: roughly 24 volunteers, average age around 58, 3% teprenone, six months.
The instrument readings are the honest part. Firmness up by around 35 percent. Tone improved. Pore size and redness down. Pigmented spots reduced.
If that were the whole claim, it would be an ordinary and defensible cosmetic result. Small, unblinded, in-house, but a real measurement of a real outcome. That is exactly why our register grades the appearance benefit [C] rather than dismissing it.
Now look at what is missing. The study was constructed to support a telomere claim, and telomere length was never measured. Nothing in it shows a telomere lengthening, or shortening more slowly, in human skin. No independent laboratory has since demonstrated a topical teprenone altering telomeres, telomerase, or cell lifespan in living skin.
The single word doing all the commercial work is the one thing the trial did not check.
We grade that claim [F], which is rare in this register. Not because the ingredient is inert, and not because the study is fabricated, but because a mechanism claim with no measurement behind it is not weak evidence. It is an absence dressed as a finding.
Most overreach in skincare is a stretch: a laboratory finding pushed toward a human claim, or an ingestible result borrowed for a cream. We map that pattern in outcome substitution.
Teprenone is the cleanest specimen of a specific variant, and it gives you a test you can carry to any product.
Did any study measure the mechanism in the claim, or only how skin looked?
If a serum promises telomere protection and the trial behind it measured firmness and pore size in the manufacturer's own lab, the mechanism is decoration. The appearance change may be perfectly real and worth paying for. The biology in the headline is a story the study never tested, and no amount of instrument data about pores can support a claim about chromosomes.
Once you have that question, you will use it constantly. It cuts through DNA repair claims, cellular energy claims, mitochondrial claims and stem cell claims in about ten seconds each.
| Outcome | Grade | Why |
|---|---|---|
| Look of firmness, tone and pores in mature skin | [C] | Plausible, but one unblinded manufacturer trial of 24 people |
| Antioxidant, environmental-stress appearance | [C] | Real heat-shock and antioxidant biology, modest on-skin payoff |
| Look of dark spots | [D] | One lab finding plus the in-house figure; not a proven brightening active |
| Lengthens telomeres, renewal at DNA level | [F] | The headline claim, and the least supported thing about the ingredient |
An ingredient whose best grade rests on a study that would be unremarkable if it were not carrying a Nobel-winning word on its back.
This is not only an evidence question in Europe, and that is worth knowing before you assume the claim is merely optimistic.
Teprenone is a permitted cosmetic ingredient in the EU and UK, and appearance claims are fine. But telomere, DNA and cellular-renewal mechanism wording sits outside what a cosmetic may say under the EU claims rules. In the United States the same wording would push a product toward being a drug claim rather than a cosmetic one.
So a serum making the telomere argument to a European reader is not merely overstating its evidence. It is using wording that the claims framework does not permit.
Teprenone is a real, tolerable, mildly antioxidant molecule with a modest single-study case for the appearance of firmer mature skin, and one of the boldest unearned headlines in the category bolted on top.
If it is in a formulation you like and the price is ordinary, it is a reasonable inclusion. Nothing about it is harmful, and the appearance data, thin as it is, points the right way.
If it is the reason for a significant price step, understand what you are buying. Not a cellular renewal treatment. Not telomere protection. A stomach-ulcer molecule in carrier oil, with one in-house trial that measured pore size and never once looked at a chromosome.
The claim on the box was never tested. It was never even measured.
Does teprenone lengthen telomeres? There is no evidence that it does. The only supporting study did not measure telomere length, and no independent laboratory has shown a topical teprenone altering telomeres, telomerase or cell lifespan in human skin. We grade that claim [F].
Is Renovage the same as teprenone? Yes. Renovage is Sederma's trademarked preparation of teprenone in a carrier oil, launched around 2007. The molecule is also geranylgeranylacetone, a prescription anti-ulcer drug in Japan since 1984.
Does teprenone do anything at all? Probably something modest. One manufacturer trial of about 24 volunteers reported improved firmness, tone, pore size and redness over six months at 3%. We grade that appearance benefit [C]: plausible and worth acknowledging, resting entirely on a single unblinded in-house study.
Is it safe? It is a permitted cosmetic ingredient in the EU, UK and US, and is generally well tolerated. Safety is not the issue with this ingredient; the claim is.
Should I pay extra for a telomere serum? Not for the telomere argument, which is untested rather than merely unproven. If the formula is otherwise good and reasonably priced, the ingredient does no harm and may contribute a little. Judge it as an antioxidant with a small file, not as anti-ageing at the DNA level.
Why grade it F rather than D? A D generally means a claim outruns its evidence. An F here means something more specific: the mechanism was never measured at all. The distinction matters because it tells you no amount of reading will find the supporting data. There is nothing to find.
This article is neutral educational reference from Vallydia, graded on the evidence. It concerns the appearance of skin and is not medical advice. Vallydia does not sell a teprenone product. For a persistent skin concern, consult a qualified dermatologist.
Full evidence breakdown: Teprenone · how we grade.
Vallydia sells its own cosmetic serums, and some ingredients discussed here belong to the same categories as those products. Assessments are drawn from the published evidence by the method we publish, and applied to our own ingredients on the same terms — our copper-peptide serum is graded no more kindly than the peptides it competes with. We disclose the interest so you can weigh it.
Brand and trade names appearing in these articles are the property of their respective owners and are used only to identify the product or ingredient under discussion. Their appearance implies no affiliation with, or endorsement by, the proprietor. Where we judge a claim, we are judging the published evidence for that claim — not making a statement about the company that makes it.
A neutral reference and a lawful-lane shop. Information for those who seek it — never promotion.
This site provides neutral scientific reference and sells only products lawful in your region. Nothing here is medical advice, a recommendation, or an offer to supply unapproved medicines. No dosing or administration is published for research compounds. Cosmetic peptides per Regulation (EC) 1223/2009. Unapproved injectable peptides are neither sold nor advertised in the EU (Directive 2001/83/EC, Title VIII). © 2026 Vallydia.